Evidence map›Paper›PMID 33809239›Full record

ArticleViruses2021

Expression and Purification of a PEDV-Neutralizing Antibody and Its Functional Verification.

Wenshu Shi, Haiyang Hao, Mengran Li, Jianqin Niu, Yaning Hu, Xingbo Zhao, Qiuyan Li

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wenshu ShiCollege of Animal Science and Technology, China Agricultural University, Beijing 100193, China.
Haiyang HaoCollege of Biological Sciences, China Agricultural University, Beijing 100193, China.
Mengran LiCollege of Biological Sciences, China Agricultural University, Beijing 100193, China.
Jianqin NiuCollege of Biological Sciences, China Agricultural University, Beijing 100193, China.
Yaning HuCollege of Animal Science and Technology, China Agricultural University, Beijing 100193, China.
Xingbo ZhaoCollege of Animal Science and Technology, China Agricultural University, Beijing 100193, China.
Qiuyan LiCollege of Biological Sciences, China Agricultural University, Beijing 100193, China.ORCID 0000-0002-5576-349X
China Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porcine epidemic diarrhea virus (PEDV) is a highly infectious and pathogenic virus causing high morbidity and mortality, especially in newborn piglets. There remain problems with contemporary PEDV vaccines, in part because of the rapid variation of PEDV, poor conferred immunity, and numerous side effects. The ability to produce PEDV-neutralizing antibodies suggests that we may be able to increase the success rate of PEDV prevention in piglets using these antibodies. In this study, we produced an anti-PEDV S protein monoclonal antibody (anti-PEDV mAb-2) that neutralized PEDV-CV777 (a G1 strain), PEDV-SDSX16 and PEDV-Aj1102 (two G2 strains). In vivo challenge experiments demonstrated that anti-PEDV mAb-2 inhibited the PEDV infection in piglets. We also produced three HEK293 cell lines that expressed anti-PEDV mAb-2. Overall, our study showed that anti-PEDV mAb-2 produced from hybridoma supernatants effectively inhibited PEDV infection in piglets, and the recombinant HEK293 cell lines expressed anti-PEDV mAb-2 genes.

Indexed as

Coronavirus InfectionsSwine DiseasesAnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralChlorocebus aethiopsHEK293 CellsHumansPorcine epidemic diarrhea virusSwineVero CellsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, Viraleukaryotic expression vectorneutralizing antibodyoral administrationPEDV

Identifiers

PMID33809239
PMCPMC7999980
OpenAlexW3137534020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.